Get the app!
Back to Trades
Grant4

Travere Therapeutics, Inc.

TVTX

Total Value
$0

Company Information

Ticker Symbol
TVTX
CIK
0001438533

Insider Information

Role
Insider
Location
SAN DIEGO, CA

Filing Details

Filing Date
Apr 15, 2026
Transaction Date
Apr 13, 2026
Accession Number
0001698262-26-000002
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Apr 13, 2026Common Stock14,000Grant/Award

Footnotes

  1. (F1)On January 31, 2025, the reporting person was granted performance restricted stock units (PSUs) which PSUs vested on April 13, 2026 upon the Issuer's confirmation that the U.S. Food and Drug Administration (FDA) had granted approval of FILSPARI (sparsentan) in FSGS.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.